PHR
Phreesia Inc
Price:  
24.78 
USD
Volume:  
905,095.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PHR EV/EBITDA

-171.2%
Upside

As of 2024-12-12, the EV/EBITDA ratio of Phreesia Inc (PHR) is -19.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PHR's latest enterprise value is 1,364.20 mil USD. PHR's TTM EBITDA according to its financial statements is -68.65 mil USD. Dividing these 2 quantities gives us the above PHR EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.8x - 16.8x 14.0x
Forward P/E multiples 16.1x - 19.4x 17.6x
Fair Price (17.99) - (18.82) (17.64)
Upside -172.6% - -176.0% -171.2%
24.78 USD
Stock Price
(17.64) USD
Fair Price

PHR EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-02 -16.77
2024-11-29 -16.72
2024-11-27 -16.10
2024-11-26 -16.13
2024-11-25 -16.15
2024-11-22 -15.74
2024-11-21 -15.01
2024-11-20 -14.60
2024-11-19 -14.63
2024-11-18 -14.85
2024-11-15 -14.20
2024-11-14 -16.69
2024-11-13 -17.83
2024-11-12 -17.00
2024-11-11 -17.25
2024-11-08 -16.90
2024-11-07 -16.65
2024-11-06 -16.85
2024-11-05 -14.67
2024-11-04 -14.55
2024-11-01 -14.56
2024-10-31 -14.41
2024-10-30 -14.58
2024-10-29 -14.47
2024-10-28 -14.44
2024-10-25 -14.38
2024-10-24 -14.29
2024-10-23 -14.50
2024-10-22 -15.50
2024-10-21 -15.52
2024-10-18 -15.68
2024-10-17 -16.19
2024-10-16 -16.56
2024-10-15 -16.72
2024-10-14 -16.72
2024-10-11 -16.68
2024-10-10 -16.26
2024-10-09 -16.63
2024-10-08 -16.99
2024-10-07 -17.01
2024-10-04 -17.69
2024-10-03 -17.59
2024-10-02 -17.84
2024-10-01 -17.83
2024-09-30 -18.20
2024-09-27 -18.14
2024-09-26 -17.70
2024-09-25 -17.91
2024-09-24 -18.34
2024-09-23 -18.79